ZYPREXA Zydis is a Oral Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Olanzapine.
Product ID | 0002-4454_7184cd07-6f72-4413-9d11-daa74ef14b03 |
NDC | 0002-4454 |
Product Type | Human Prescription Drug |
Proprietary Name | ZYPREXA Zydis |
Generic Name | Olanzapine |
Dosage Form | Tablet, Orally Disintegrating |
Route of Administration | ORAL |
Marketing Start Date | 2000-06-01 |
Marketing Category | NDA / NDA |
Application Number | NDA021086 |
Labeler Name | Eli Lilly and Company |
Substance Name | OLANZAPINE |
Active Ingredient Strength | 10 mg/1 |
Pharm Classes | Atypical Antipsychotic [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2000-06-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021086 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2000-06-01 |
Marketing Category | NDA |
Application Number | NDA021086 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2000-06-01 |
Marketing Category | NDA |
Application Number | NDA021086 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2000-06-01 |
Marketing End Date | 2012-10-25 |
Ingredient | Strength |
---|---|
OLANZAPINE | 10 mg/1 |
SPL SET ID: | d5051fbc-846b-4946-82df-341fb1216341 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0002-4456 | ZYPREXA Zydis | ZYPREXA Zydis |
0002-4112 | Zyprexa | Olanzapine |
0002-4115 | Zyprexa | Olanzapine |
0002-4116 | Zyprexa | Olanzapine |
0002-4117 | Zyprexa | Olanzapine |
0002-4415 | Zyprexa | Olanzapine |
0002-4420 | Zyprexa | Olanzapine |
0002-4453 | ZYPREXA | Olanzapine |
0002-4454 | ZYPREXA | Olanzapine |
0002-4455 | ZYPREXA | Olanzapine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZYPREXA 75078626 2072867 Live/Registered |
Eli Lilly and Company 1996-03-26 |